-- Days : -- HRS : -- MIN : -- SEC

Register Now →

Marrium Z. Qureshi, PharmD

Articles by Marrium Z. Qureshi, PharmD

FDA

FDA Approves Belumosudil (Rezurock) for the Treatment of Patients with Chronic Graft-Versus-Host Disease (cGVHD)

ByMarrium Z. Qureshi, PharmD,Kevin W. Chamberlin, PharmD

October 27th 2021

Latest Updated Articles

Trending on Drug Topics

Long-Term Adverse Effects After COVID-19 Vaccination Vary by Brand

Expert Discusses Flu and COVID-19 Vaccine Guidance

Explaining COVID-19 Vaccine Side Effects to Anxious Patients

AI, Automation Are Transforming Pharmacies into Proactive Care Hubs

Student Pharmacists Can Actively Drive Community Health